|
3,4,5-Trichlorosyringol
|
|
2539-26-6
|
|
17-DMAP-GA
|
|
169521-68-0
|
|
SB-209670
|
|
157659-79-5
|
|
Hepatitis Virus C NS3 Protease Inhibitor 2
|
|
208939-95-1
|
|
Aeruginosin 865
|
|
1611990-01-2
|
|
NPEC-caged-LY379268
|
|
1315379-62-4
|
|
(-)-SHIN1
|
|
2444764-09-2
|
|
Microcolin B
|
|
141205-32-5
|
|
N-(Biotin-PEG4)-N-bis(PEG4-acid)
|
|
2112731-48-1
|
|
DBCO-C2-SulfoNHS ester
|
|
1803279-86-8
|
|
(R)-Plevitrexed
|
|
153537-74-7
|
|
T3-ATA (S-isomer)
|
|
2438721-48-1
|
|
FR167344 free base
|
|
215258-13-2
|
|
ML786 dihydrochloride
|
|
1237536-18-3
|
|
TFAX 488,TFP
|
|
878546-79-3
|
|
ERRγ Inverse Agonist 1
|
|
2316832-86-5
|
|
Phthalimide-PEG3-C2-OTs
|
|
382162-12-1
|
|
LY3020371
|
|
1377615-75-2
|
|
MK-447
|
|
58456-91-0
|
|
Dox-Ph-PEG1-Cl
|
|
773095-86-6
|
|
Prinomide tromethamine
|
|
109636-76-2
|
|
PD-1/PD-L1-IN 5 TFA
|
|
2170209-52-4
|
|
7-Oxotridecanedioic acid
|
|
101171-43-1
|
|
17-GMB-APA-GA
|
|
256337-10-7
|
|
9,10-Dichlorostearic acid
|
|
5829-48-1
|
|
A3334
|
|
854171-31-6
|
|
PYBG-BODIPY
|
|
2068027-79-0
|
|
Lesopitron
|
|
132449-46-8
|
|
Erythromycin ethylsuccinate-
|
|
2375781-06-7
|
|
Cys modifier 1
|
|
2374314-08-4
|
|
PF-06795071
|
|
2075629-81-9
|
|
MK-6240 Precursor
|
|
1841444-11-8
|
|
6-trans-12-epi-Leukotriene B4
|
|
71548-19-1
|
|
ML-9 Free Base
|
|
110448-31-2
|
|
SL910102
|
|
144756-71-8
|
|
Adenosine 5'-succinate
|
|
102029-71-0
|
|
Daclatasvir Impurity C
|
|
1256385-55-3
|
|
1-(4-(4-(8-oxa-3-azabicyclo[3.2.1]octan-3-yl)thieno[3,2-d]pyrimidin-2-yl)phenyl)-3-cyclopropylurea
|
|
1144075-40-0
|
|
1,3-Dibromo-1,3-dichloroacetone
|
|
62874-84-4
|
|
JMS-17-2 hydrochloride
|
|
2341841-07-2
|
|
Mukanadin C
|
|
1839104-78-7
|
|
UCB-J
|
|
2242957-52-2
|
|
Timobesone
|
|
87116-72-1
|
|
DOTA derivative
|
|
153777-70-9
|
|
Urinary Incontinence-Targeting Compound 1
|
|
137315-05-0
|
|
N-acetyl Dapsone (D4')
|
|
2070015-28-8
|
|
Diarylalkane derivative 1
|
|
191155-65-4
|
|
chaetoglobosin Vb
|
|
1399690-75-5
|
|
Orotidine 5′-monophosphate
|
|
2149-82-8
|
|
Maltoheptaose hydrate
|
|
331748-09-5
|
|
(R,1R)-Tenofovir amibufenamide
|
|
1571076-37-3
|
|
(S,R,S)-AHPC-Me-C10-NH2 hydrochloride
|
|
2471970-07-5
|
|
Chitohexaose hexahydrochloride
|
|
127171-88-4
|
|
SW209049
|
|
1673558-59-2
|
|
Seclazone
|
|
29050-11-1
|
|
CHMFL-KIT-033
|
|
2351801-41-5
|
|
JTK-109
|
|
480462-62-2
|
|
HKOCl-4
|
|
2031170-85-9
|
|
Soluplus
|
|
402932-23-4
|
|
1,2-diphenylpropan-2-amine
|
|
118910-28-4
|
|
MK-8325 dihydrochloride
|
|
1334314-19-0
|
|
Neurodegenerative Disorder-Targeting Compound 1
|
|
1254698-39-9
|
|
SR121566A
|
|
180144-61-0
|
|
BILB-1941
|
|
494856-61-0
|
|
GW-493838
|
|
253124-46-8
|
|
NCOA4 - 9a
|
|
2650557-72-3
|
|
1,1-Dibromo-3-chloroacetone
|
|
1578-18-3
|
|
Atorvastatin lactone D5
|
|
1217749-86-4
|
|
5,6-Dichlorovanillin
|
|
18268-69-4
|
|
CGP-53153
|
|
149281-19-6
|
|
Thiamine diphosphate analog 1
|
|
2606-90-8
|
|
Aβ42-IN-1 free base
|
|
2434633-17-5
|
|
Rocagloic acid
|
|
190385-15-0
|
|
Kgp-IN-1 hydrochloride
|
|
2097865-47-7
|
|
TV 3279
|
|
209394-29-6
|
|
19-Heptatriacontanol
|
|
872307-34-1
|
|
Tebufelone
|
|
112018-00-5
|
|
PI5P4Ks-IN-2
|
|
2766854-03-7
|
|
O-Methylpodocarpic acid
|
|
10037-26-0
|
|
LH secretion antagonist 1
|
|
88531-67-3
|
|
BI-1230
|
|
849022-32-8
|
|
2H-Pyrido[2',1':3,4]pyrazino[1,2-b]indazole-3-carboxylic acid, 6-(1,1-dimethylethyl)-6,7-dihydro-10-(3-methoxypropoxy)-2-oxo-, (6R)-
|
|
2247932-38-1
|
|
WCK-5153
|
|
1436862-38-2
|
|
4-Aza-Oleanolic acid methyl ester
|
|
557766-15-1
|
|
Elacestrant S enantiomer dihydrochloride
|
|
2309762-30-7
|
|
Ilmetropium iodide
|
|
129109-88-2
|
|
TRC-766
|
|
1810734-44-1
|
|
Eptifibatide acetate
|
|
1248559-53-6
|
|
Bimosiamose disodium
|
|
187269-60-9
|
|
LY-402913
|
|
334970-65-9
|
|
T4-ATA (S-isomer)
|
|
2448470-97-9
|
|
RDR03871
|
|
286008-51-3
|
|
Usmarapride
|
|
1428862-33-2
|
|
1-(2-fluoroethyl)-3-{4-[4-(8-oxa-3-azabicyclo[3.2.1]oct-3-yl)thieno[3,2-d]pyrimidin-2-yl]phenyl}urea
|
|
1144075-36-4
|
|
Opaviraline
|
|
178040-94-3
|
|
Chitoheptaose heptahydrochloride
|
|
127171-89-5
|
|
Glycosidase-IN-1
|
|
170376-12-2
|
|
RIP2 kinase inhibitor 1
|
|
2380028-10-2
|
|
NH2-C2-amido-C2-Boc
|
|
1692613-62-9
|
|
H-Asn-Arg-OH
|
|
2478-01-5
|